Related Experiment Videos
Liposomes as oral adjuvants
Current Topics in Microbiology and Immunology
|January 1, 1989
Summary
Liposomes enhance oral vaccine effectiveness by acting as carriers for soluble antigens and adjuvants, significantly boosting mucosal immune responses compared to antigen alone. Lipophilic MDP further improves these responses, supporting oral vaccine development.
Area of Science:
- Vaccinology
- Immunology
- Biotechnology
Background:
- Liposomes are investigated as potential carriers for oral vaccines.
- Mucosal immune responses are crucial for protection against infectious diseases.
- Current oral vaccine strategies require enhancement for improved efficacy.
Purpose of the Study:
- To review the efficacy of liposomes as carriers and adjuvants in oral vaccines.
- To explore methods for characterizing liposome preparations for vaccine development.
- To highlight the potential of recombinant DNA technology in creating novel oral vaccines.
Main Methods:
- Review of existing literature on liposomes in oral vaccination.
- Description of a flow cytometry method for liposome characterization.
- Analysis of data on mucosal responses to liposomal antigen delivery.
Main Results:
- Oral administration of antigens encapsulated in liposomes significantly augments mucosal immune responses.
- Lipophilic muramyl dipeptide (MDP) incorporation further enhances these specific mucosal responses.
- Flow cytometry provides a rapid and reproducible method for liposome characterization.
Conclusions:
- Liposomes are effective carriers and adjuvants for oral vaccines, enhancing mucosal immunity.
- Liposome characterization using flow cytometry is a valuable tool for vaccine development.
- Recombinant DNA techniques hold promise for developing safe and effective oral vaccines.